ORACLE CORP
For the period ended Feb 28, 2025. Filed Mar 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 28, 2025 · Filed Mar 11, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-11-30; filed 2024-12-10.
0000950170-24-134973
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationCurrent report: 10-Q
Period ended 2025-02-28; filed 2025-03-11.
0000950170-25-037143
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 11 previous paragraphs and 11 current paragraphs.
9 unchanged; 1 reworded; 1 added; 1 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
Jeffrey O. Henley, our Vice Chairman of the Board of Directors, adopted a new trading plan on December 31, 2024. Mr. Henley’s plan isscheduled to terminate on July 2, 2025, subject to early termination for certain specified events set forth therein. The trading plan is intended to permit Mr. Henley to exercise and sell 400,000 stock options expiring on July 2, 2025.
Removed paragraphs (1)
Previous report
Safra Catz, our Chief Executive Officer and Director, adopted a new trading plan on September 25, 2024. The plan’s maximum duration is until July 20, 2025, and first trades will not occur until January 2, 2025, at the earliest. The trading plan is intended to permit Ms. Catz to exercise and sell the following performance stock options (PSOs) granted on July 20, 2017 andset to expire on July 20, 2025: (i)7,500,000 currently vested PSOs; and (ii) any PSOs that vest in the future based on fiscal year 2025 performance.
Reworded paragraphs (1)
Previous wording
Our Board of Directors has approved a program for us to repurchase shares of our common stock. As of November 30, 2024, approximately $6.7 billion remained available for stock repurchases pursuant to our stock repurchase program.
Current wording
Our Board of Directors has approved a program for us to repurchase shares of our common stock. As of February 28, 2025, approximately $6.5 billion remained available for stock repurchases pursuant to our stock repurchase program.